NEXAFED- pseudoephedrine hcl tablet
Acura Pharmaceuticals, Inc.
Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.
----------
Do not exceed recommended dosage
If nervousness, dizziness or sleeplessness occurs, discontinue use and consult a doctor.
If symptoms do not improve within 7 days or are accompanied by a fever, consult a doctor.
Do not use if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric or emotional conditions, or Parkinson’s disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription contains an MAOI, ask a doctor or pharmacist before taking this product.
Do not take this product if you have
In case of overdose, get medical help or contact a Poison Control Center right away.
adults and children 12 years and over |
2 tablets |
children 6 years to under 12 years |
1 tablet |
children under 6 years |
ask a doctor |
Inactive ingredients colloid silicon dioxide, crospovidone, hydroxypropyl cellulose, magnesium stearate, microcrystalline cellulose and polyethylene oxide.
nexafed®
PSEUDOEPHEDRINE HYDROCHLORIDE 30MG
NASAL DECONGESTANT
Battle congestion. And meth abuse too.
JOIN THE FIGHT.
MANUFACTURED FOR:
MainPointe Pharmaceuticals, LLC
Louisville, KY 40202
US Patent Number 10,400,699
NDC 48964-112-24
24
TABLETS
NEXAFED
pseudoephedrine hcl tablet |
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
Labeler - Acura Pharmaceuticals, Inc. (001315530) |
Establishment | |||
Name | Address | ID/FEI | Business Operations |
---|---|---|---|
Patheon Pharmaceuticals, Inc. | 005286822 | api manufacture(48964-112) |